Indefinite Delivery Contract W81XWH12D0023

The University of North Texas Health Science Center at Fort Worth (UNTHSC) has been awarded a multiple-award Blanket Purchase Agreement (BPA) by the Drug Enforcement Administration (DEA) valued at $833,580.73 to conduct in vivo pharmacological studies evaluating the abuse potential of synthetic cannabinoids and phytocannabinoids. This civilian contract, awarded on March 20, 2026, with an ultimate completion date of March 19, 2031, represents an open competition vehicle with no set-asides....

The National Institute on Drug Abuse (NIDA), a civilian agency, has awarded an Indefinite Delivery Contract (IDC) valued at up to $10,000,000 to Benuvia Operations, LLC, a for-profit organization. The 5-year IDC, awarded on March 14, 2025, will provide GMP synthesis of bulk drug substances, including the synthesis of GMP psilocybin, for NIDA's toxicological and clinical trials program. The contract requires the vendor to have the capability to manufacture both GMP and non-GMP bulk drug...

The Department of Justice Drug Enforcement Administration awarded a single-award blanket purchase agreement to Government Scientific Source Inc. with a potential value of $1,250,000.00 and a period of performance from September 2021 through September 2026. Under the terms of the agreement and an initial BPA call valued at $249,000, Government Scientific Source Inc. will perform synthesis of chemical substances for diversion and control purposes at its facility in Herndon, Virginia through...

The National Institute on Drug Abuse (NIDA), a civilian agency under the Department of Health and Human Services, has awarded an Indefinite Delivery Contract to Research Triangle Institute (RTI International), a non-profit research organization, to provide synthesis and distribution services for drugs of abuse and related compounds. The contract has a ceiling value of $14,004,330 and a period of performance from June 9, 2022 to June 8, 2027. This contract supports NIDA's mission of conducting...

The Defense Health Agency (DHA) awarded a single-award Blanket Purchase Agreement (BPA) contract worth up to $1,500,000 to Cayman Chemical Co Inc., a for-profit manufacturer of biochemical products and research tools located in Ann Arbor, Michigan. The BPA, which does not have a small business set-aside, is for the provision of chemicals, synthetic cannabinoids, and novel psychoactive substances to support the DHA's drug testing and medical supply needs through September 2027. Under this BPA,...

The Drug Enforcement Administration (DEA) Diversion Control Division awarded a single-award, five-year Blanket Purchase Agreement (BPA) valued at $1,031,685.80 to The University of North Texas Health Science Center at Fort Worth (UNTHSC) for synthetic opioids testing, effective September 30, 2024 through September 30, 2029. This civilian contract, awarded without a set-aside designation, establishes a framework for UNTHSC to provide investigational studies and methodology for evaluating the...

The Department of Justice's Drug Enforcement Administration (DEA) awarded a single-award Blanket Purchase Agreement (BPA) to The Regents of the University of California, San Francisco (UCSF) to provide toxicology testing services of biological samples from overdose patients resulting from the ingestion of novel psychoactive substances. The BPA has a $3,740,720 ceiling value and a period of performance through July 2029. Under this IDV, the DEA has issued multiple firm fixed price call orders...

The National Institute on Drug Abuse (NIDA), a civilian federal agency, awarded a single-award Indefinite Delivery Contract to Research Triangle Institute (RTI International), a non-profit research organization, for the preparation and distribution of research drug products. The $19,975,000 contract has a period of performance from March 20, 2025 to March 19, 2029, with a final completion date of March 19, 2026 for the initial $1,497,865 delivery order. RTI International, an experienced...

The Drug Enforcement Administration awarded a single-award Blanket Purchase Agreement to the University of Arkansas for Medical Sciences with a ceiling value of $1,803,619.58 and a performance period extending through September 1, 2029. This civilian federal contract, established without small business set-aside designation, was issued to support the DEA's research and regulatory objectives related to controlled substance evaluation. The BPA was created through a Request for Quote process with...

The National Institute on Drug Abuse (NIDA), a civilian agency within the Department of Health and Human Services, awarded a single-award Indefinite Delivery Contract (IDC) to Polypeptide Laboratories San Diego, LLC (doing business as Polypeptide Labs) in February 2022. The $2,781,317 contract covers the synthesis and distribution of opioid and related peptides over a 5-year period of performance from February 15, 2022 to February 14, 2027. Polypeptide Labs, a specialized manufacturer of...